Crossmark

Plasma rich in growth factors (PRGF) and leukocyte-platelet rich fibrin (L-PRF): comparative release of growth factors and biological effect on osteoblasts

Crossref DOI link: https://doi.org/10.1186/s40729-022-00440-4

Published Online: 2022-10-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Baca-Gonzalez, Laura http://orcid.org/0000-0002-5251-7533
Serrano Zamora, Rebeca

Rancan, Lisa

González Fernández-Tresguerres, Francisco

Fernández-Tresguerres, Isabel

López-Pintor, Rosa M.

López-Quiles, Juan

Leco, Isabel

Torres, Jesús
License Information

Text and Data Mining valid from 2022-10-03

Version of Record valid from 2022-10-03
More Information

Article History

Received: 28 March 2022

Accepted: 13 September 2022

First Online: 3 October 2022

Declarations

:

: All volunteers signed an informed consent prior to their inclusion. The study was performed in accordance with the Helsinki Declaration of 1975 and the study protocol was reviewed and approved by the Ethical Committee for Clinical Trials of the “Hospital Clínico San Carlos” to carry out the study at “Complutense University” (Madrid, Spain) (Protocol number 20/497-E).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below